DK1236728T3 - S-type 2-substituerede hydroxy-2-indolidinylsmörsyreesterforbindelser og fremgangsmåde til fremstilling deraf - Google Patents

S-type 2-substituerede hydroxy-2-indolidinylsmörsyreesterforbindelser og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1236728T3
Authority: DK; Denmark
Prior art keywords: type; preparation; acid ester; ester compounds; substituted hydroxy
Prior art date: 1996-10-30

Application number

DK02006610T

Other languages

English (en)

Inventor

Takayuki Kawaguchi

Kenji Tsujihara

Sumihiro Nomura

Original Assignee

Tanabe Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-30

Filing date

1997-10-27

Publication date

2006-10-30

1997-10-27 Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co

2006-10-30 Application granted granted Critical

2006-10-30 Publication of DK1236728T3 publication Critical patent/DK1236728T3/da

Links

-1 ester compounds Chemical class 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000002253 acid Substances 0.000 title 1
230000010933 acylation Effects 0.000 abstract 1
238000005917 acylation reaction Methods 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
150000001732 carboxylic acid derivatives Chemical class 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
238000003402 intramolecular cyclocondensation reaction Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
229910052757 nitrogen Inorganic materials 0.000 abstract 1
125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
230000009935 nitrosation Effects 0.000 abstract 1
238000007034 nitrosation reaction Methods 0.000 abstract 1
230000008707 rearrangement Effects 0.000 abstract 1
238000006462 rearrangement reaction Methods 0.000 abstract 1
230000009467 reduction Effects 0.000 abstract 1
238000006722 reduction reaction Methods 0.000 abstract 1

Classifications

- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1345—Conductors connecting electrodes to cell terminals
- G02F1/13452—Conductors connecting driver circuitry and terminals of panels
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/1303—Apparatus specially adapted to the manufacture of LCDs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Physics & Mathematics (AREA)
Nonlinear Science (AREA)
Health & Medical Sciences (AREA)
Crystallography & Structural Chemistry (AREA)
General Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Manufacturing & Machinery (AREA)
Mathematical Physics (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

DK02006610T 1996-10-30 1997-10-27 S-type 2-substituerede hydroxy-2-indolidinylsmörsyreesterforbindelser og fremgangsmåde til fremstilling deraf DK1236728T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP28807496		1996-10-30
EP97308549A EP0845464B1 (en)	1996-10-30	1997-10-27	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds as intermediates for camptothecin derivatives

Publications (1)

Publication Number	Publication Date
DK1236728T3 true DK1236728T3 (da)	2006-10-30

Family

ID=17725479

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK97308549T DK0845464T3 (da)	1996-10-30	1997-10-27	S-type 2-substituerede hydroxy-2-indolidinylsmørsyreesterforbindelser som mellemprodukter for camptothecinderivater
DK02006610T DK1236728T3 (da)	1996-10-30	1997-10-27	S-type 2-substituerede hydroxy-2-indolidinylsmörsyreesterforbindelser og fremgangsmåde til fremstilling deraf

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK97308549T DK0845464T3 (da)	1996-10-30	1997-10-27	S-type 2-substituerede hydroxy-2-indolidinylsmørsyreesterforbindelser som mellemprodukter for camptothecinderivater

Country Status (14)

Country	Link
US (7)	US5932732A (da)
EP (3)	EP0845464B1 (da)
KR (5)	KR100474496B1 (da)
CN (3)	CN100473654C (da)
AT (2)	ATE332303T1 (da)
CA (2)	CA2219692C (da)
DE (2)	DE69736308T2 (da)
DK (2)	DK0845464T3 (da)
ES (2)	ES2267879T3 (da)
HK (1)	HK1050356B (da)
ID (1)	ID18747A (da)
PT (2)	PT845464E (da)
SG (4)	SG88737A1 (da)
TW (1)	TW464652B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG88737A1 (en) *	1996-10-30	2002-05-21	Tanabe Seiyaku Co	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
HUP0302352A3 (en)	2000-11-09	2007-03-28	Neopharm	Sn-38 lipid complexes and methods of use
US20090137816A1 (en) *	2000-12-15	2009-05-28	Kurt Baum	Process for the manufacture of diaminofurazan
US6350756B1 (en)	2001-01-18	2002-02-26	California Pacific Medical Center	Camptothecin derivatives
CN101337900B (zh) *	2001-02-21	2013-12-18	株式会社雅库路特本社	喜树碱相关化合物的合成方法
AR035684A1 (es) *	2001-02-21	2004-06-23	Yakult Honsha Kk	Procedimiento para preparar 2'-amino-5'-hidroxipropiofenona, uso de la misma para la preparacion de analogos de camptotecina, procedimiento para prepararlos, compuestos intermediarios, procedimiento para preparar una cetona triciclica utilizada en la sintesis de analogos de camptotecina
US6855720B2 (en)	2001-03-01	2005-02-15	California Pacific Medical Center	Nitrogen-based camptothecin derivatives
US6403604B1 (en)	2001-03-01	2002-06-11	California Pacific Medical Center	Nitrogen-based camptothecin derivatives
WO2003030864A1 (en) *	2001-05-29	2003-04-17	Neopharm, Inc.	Liposomal formulation of irinotecan
US6933302B2 (en) *	2002-06-03	2005-08-23	California Pacific Medical Center	Nitrogen-based homo-camptothecin derivatives
AU2003243397A1 (en) *	2002-06-03	2003-12-19	California Pacific Medical Center	Homo-camptothecin derivatives
AU2003296897A1 (en) *	2002-08-20	2004-05-04	Neopharm, Inc.	Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) *	2002-08-20	2006-02-09	Neopharm, Inc.	Pharmaceutically active lipid based formulation of irinotecan
JP4433918B2 (ja) *	2004-07-15	2010-03-17	コニカミノルタエムジー株式会社	画像形成方法
KR100651728B1 (ko) *	2004-11-10	2006-12-06	한국전자통신연구원	정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
CN100390177C (zh) *	2004-11-25	2008-05-28	复旦大学	6-氰基-7-甲基-1,1-(2,2-二甲基-1,3-亚丙二氧基)-5-氧-1,2,3,5-四氢吲哚哩啶(i)的制备方法
US7608740B2 (en)	2005-08-03	2009-10-27	Avra Laboratories Pvt. Ltd	Method of synthesizing key intermediates for the production of camptothecin derivatives
US7875602B2 (en) *	2005-10-21	2011-01-25	Sutter West Bay Hospitals	Camptothecin derivatives as chemoradiosensitizing agents
CN104341429B (zh) *	2013-07-29	2016-08-10	北大方正集团有限公司	(s)-喜树碱中间体的制备方法及(s)-喜树碱的制备方法
CN111936169A (zh) *	2018-04-06	2020-11-13	西雅图遗传学公司	喜树碱肽缀合物
TWI920652B (zh)	2018-06-07	2026-04-01	美商思進公司	喜樹鹼結合物
CN113041841B (zh) *	2021-03-22	2022-07-12	万华化学集团股份有限公司	一种抗污染浓水隔网的制备方法及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4399282A (en) *	1979-07-10	1983-08-16	Kabushiki Kaisha Yakult Honsha	Camptothecin derivatives
JPS5711607A (en) *	1980-06-25	1982-01-21	Tokyo Shibaura Electric Co	Movable shelf control apparatus
JPS57116074A (en)	1981-01-09	1982-07-19	Yakult Honsha Co Ltd	Novel camptothecin derivative and its preparation
US4473692A (en) *	1981-09-04	1984-09-25	Kabushiki Kaisha Yakult Honsha	Camptothecin derivatives and process for preparing same
EP0220601B1 (en) *	1985-10-21	1991-12-11	Daiichi Seiyaku Co., Ltd.	Pyranoindolizine derivatives and preparation process thereof
US5053512A (en) *	1987-04-14	1991-10-01	Research Triangle Institute	Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US4981968A (en) *	1987-03-31	1991-01-01	Research Triangle Institute	Synthesis of camptothecin and analogs thereof
US5244903A (en) *	1987-03-31	1993-09-14	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5122606A (en) *	1987-04-14	1992-06-16	Research Triangle Institute	10,11-methylenedioxy camptothecins
US4939255A (en) *	1987-06-24	1990-07-03	Daiichi Pharmaceutical Co., Ltd.	Hexa-cyclic camptothecin derivatives
US4943579A (en)	1987-10-06	1990-07-24	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Water soluble prodrugs of camptothecin
JPH0615547B2 (ja) *	1988-01-20	1994-03-02	株式会社ヤクルト本社	新規なカンプトテシン誘導体
JP2524803B2 (ja) *	1988-03-29	1996-08-14	株式会社ヤクルト本社	新規なカンプトテシン誘導体およびその製造法
ES2165346T3 (es) *	1989-09-15	2002-03-16	Res Triangle Inst	Analogos de 10,11-metilendioxi-20(rs)-camptotecina y 10,11-metilendioxi-20(s)-camptotecina.
TW201303B (da) *	1990-07-05	1993-03-01	Hoffmann La Roche
HU213136B (en) *	1990-08-14	1997-02-28	Kyorin Seiyaku Kk	Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them
JP2887524B2 (ja) *	1990-11-30	1999-04-26	第一製薬株式会社	微生物による光学分割法
JP2923692B2 (ja) *	1990-11-30	1999-07-26	第一製薬株式会社	酵素による光学分割法
JPH04210675A (ja) *	1990-12-13	1992-07-31	Otsuka Pharmaceut Co Ltd	ベンゼン誘導体
DK0540099T3 (da) *	1991-10-29	1996-06-17	Glaxo Wellcome Inc	Vandopløselige camptothecinderivater
EP0556585A3 (en) *	1992-01-24	1993-09-01	Takeda Chemical Industries, Ltd.	Condensed camptothecin derivatives their production and use as antitumor agents
WO1993016698A1 (en) *	1992-02-21	1993-09-02	Smithkline Beecham Corporation	SUBSTITUTED FURO[3',4':6,7]INDOLIZINO[1,2-b]QUINOLINONES
JP3126799B2 (ja) *	1992-03-31	2001-01-22	第一製薬株式会社	光学活性カンプトテシン誘導体及びその製法
JP3126798B2 (ja) *	1992-03-31	2001-01-22	第一製薬株式会社	光学活性インドリジン誘導体及びその製法
JP3359955B2 (ja) *	1992-07-16	2002-12-24	第一製薬株式会社	抗腫瘍剤
IS4152A (is) *	1993-04-29	1994-10-30	Glaxo Inc.	Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
JPH07101956A (ja) *	1993-10-05	1995-04-18	Tanabe Seiyaku Co Ltd	ヒドロキシカンプトテシン化合物の製法
KR960029336A (ko) *	1995-01-09	1996-08-17	김충환	캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제
IL117684A (en) *	1995-04-07	2002-02-10	Pharmacia & Upjohn Inc	Intermediates and Process for Production of History of Kempotocin (CPT-11) and Related Compounds
US5728712A (en) *	1995-05-19	1998-03-17	Chiroscience Limited	3,4-disubstituted-phenylsulphonamides and their therapeutic use
SG50747A1 (en) *	1995-08-02	1998-07-20	Tanabe Seiyaku Co	Comptothecin derivatives
TR199800849T2 (xx)	1995-11-13	1998-07-21	Hoechst Aktiengesellschaft	Siklikle heterosiklik N-ikame edilmi� alfa-iminohidroksamla karbon asitleri
WO1997019085A1 (en)	1995-11-22	1997-05-29	Research Triangle Institute	Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties
CA2192725C (en) *	1995-12-28	2004-04-20	Kenji Tsujihara	Camptothecin derivatives
US5731316A (en)	1996-01-30	1998-03-24	The Stehlin Foundation For Cancer Research	Derivatives of camptothecin and methods of treating cancer using these derivatives
SG88737A1 (en) *	1996-10-30	2002-05-21	Tanabe Seiyaku Co	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
DE19719817A1 (de) *	1997-05-13	1998-11-19	Hoechst Ag	Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren

1997
- 1997-10-23 SG SG9703851A patent/SG88737A1/en unknown
- 1997-10-23 SG SG200107148A patent/SG103322A1/en unknown
- 1997-10-23 TW TW086115665A patent/TW464652B/zh not_active IP Right Cessation
- 1997-10-23 SG SG200107147A patent/SG116433A1/en unknown
- 1997-10-23 SG SG200107149A patent/SG104284A1/en unknown
- 1997-10-24 ID IDP973523A patent/ID18747A/id unknown
- 1997-10-27 DE DE69736308T patent/DE69736308T2/de not_active Expired - Fee Related
- 1997-10-27 PT PT97308549T patent/PT845464E/pt unknown
- 1997-10-27 DE DE69724081T patent/DE69724081T2/de not_active Expired - Fee Related
- 1997-10-27 EP EP97308549A patent/EP0845464B1/en not_active Expired - Lifetime
- 1997-10-27 EP EP04005684A patent/EP1528062A3/en not_active Withdrawn
- 1997-10-27 ES ES02006610T patent/ES2267879T3/es not_active Expired - Lifetime
- 1997-10-27 DK DK97308549T patent/DK0845464T3/da active
- 1997-10-27 PT PT02006610T patent/PT1236728E/pt unknown
- 1997-10-27 ES ES97308549T patent/ES2205134T3/es not_active Expired - Lifetime
- 1997-10-27 EP EP02006610A patent/EP1236728B1/en not_active Expired - Lifetime
- 1997-10-27 AT AT02006610T patent/ATE332303T1/de not_active IP Right Cessation
- 1997-10-27 DK DK02006610T patent/DK1236728T3/da active
- 1997-10-27 AT AT97308549T patent/ATE247120T1/de not_active IP Right Cessation
- 1997-10-28 US US08/958,979 patent/US5932732A/en not_active Expired - Fee Related
- 1997-10-30 KR KR1019970056330A patent/KR100474496B1/ko not_active Expired - Fee Related
- 1997-10-30 CA CA002219692A patent/CA2219692C/en not_active Expired - Fee Related
- 1997-10-30 CA CA002533685A patent/CA2533685C/en not_active Expired - Fee Related
- 1997-10-30 CN CNB011109580A patent/CN100473654C/zh not_active Expired - Fee Related
- 1997-10-30 CN CNB2006101011920A patent/CN100528879C/zh not_active Expired - Fee Related
- 1997-10-30 CN CN97122529A patent/CN1077109C/zh not_active Expired - Fee Related
1998
- 1998-10-15 US US09/172,666 patent/US6015901A/en not_active Expired - Fee Related
- 1998-12-03 HK HK03100780.1A patent/HK1050356B/en not_active IP Right Cessation
1999
- 1999-10-18 US US09/421,335 patent/US6114529A/en not_active Expired - Fee Related
2000
- 2000-05-12 US US09/570,172 patent/US6277992B1/en not_active Expired - Fee Related
2001
- 2001-07-05 US US09/898,007 patent/US6388078B1/en not_active Expired - Fee Related
2002
- 2002-04-10 US US10/118,920 patent/US7060832B2/en not_active Expired - Fee Related
2003
- 2003-01-08 US US10/337,476 patent/US6716983B2/en not_active Expired - Fee Related
2004
- 2004-04-27 KR KR1020040029222A patent/KR100525025B1/ko not_active Expired - Fee Related
- 2004-09-13 KR KR1020040072932A patent/KR100567957B1/ko not_active Expired - Fee Related
2005
- 2005-06-10 KR KR1020050049637A patent/KR100578779B1/ko not_active Expired - Fee Related
- 2005-10-29 KR KR1020050102674A patent/KR100653592B1/ko not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6716983B2 (en)	2004-04-06
EP1236728A3 (en)	2002-12-18
US6015901A (en)	2000-01-18
EP1236728A2 (en)	2002-09-04
ES2205134T3 (es)	2004-05-01
CA2533685A1 (en)	1998-04-30
MX9708343A (es)	1998-08-30
US6114529A (en)	2000-09-05
PT845464E (pt)	2003-12-31
KR20060086818A (ko)	2006-08-01
CA2533685C (en)	2009-05-26
KR100567957B1 (ko)	2006-04-05
KR19980033318A (ko)	1998-07-25
SG104284A1 (en)	2004-06-21
ID18747A (id)	1998-05-07
CN1077109C (zh)	2002-01-02
ES2267879T3 (es)	2007-03-16
US6277992B1 (en)	2001-08-21
KR100578779B1 (ko)	2006-05-12
CA2219692C (en)	2007-05-22
ATE247120T1 (de)	2003-08-15
CN1183414A (zh)	1998-06-03
DE69736308T2 (de)	2007-06-14
US20030135049A1 (en)	2003-07-17
EP1528062A2 (en)	2005-05-04
PT1236728E (pt)	2006-10-31
US6388078B1 (en)	2002-05-14
SG88737A1 (en)	2002-05-21
US20020161231A1 (en)	2002-10-31
CA2219692A1 (en)	1998-04-30
SG103322A1 (en)	2004-04-29
CN1915995A (zh)	2007-02-21
TW464652B (en)	2001-11-21
CN100473654C (zh)	2009-04-01
SG116433A1 (en)	2005-11-28
HK1050356A1 (en)	2003-06-20
US7060832B2 (en)	2006-06-13
HK1011538A1 (en)	1999-07-16
EP0845464B1 (en)	2003-08-13
DE69724081D1 (de)	2003-09-18
EP1528062A3 (en)	2007-02-07
EP1236728B1 (en)	2006-07-05
KR100474496B1 (ko)	2005-09-30
CN1313286A (zh)	2001-09-19
CN100528879C (zh)	2009-08-19
EP0845464A2 (en)	1998-06-03
DK0845464T3 (da)	2003-12-01
KR100525025B1 (ko)	2005-10-31
KR100653592B1 (ko)	2006-12-05
ATE332303T1 (de)	2006-07-15
US5932732A (en)	1999-08-03
HK1050356B (en)	2007-01-19
DE69724081T2 (de)	2004-06-09
DE69736308D1 (de)	2006-08-17
EP0845464A3 (en)	1999-06-23

Publication	Publication Date	Title
SG103322A1 (en)	2004-04-29	S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
CY2120B1 (en)	2002-04-26	Substituted heterocyclic carboxylic acid amides their preparation and their use as medicaments
DE59401923D1 (de)	1997-04-10	Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel
PL298988A1 (en)	1994-01-24	Novel derivatives of acetic acod, pharmaceutical preparation, method of obtaining such derivatives and method of obtaining initial compounds
PH24199A (en)	1990-04-10	Derivatives of quinoline carboxylic acid,pharmaceutical composition containing same and process of preparing same
IL113011A0 (en)	1995-06-29	R-mandelic acid salt of phenylpiperidine derivative
DE69427517D1 (de)	2001-07-26	Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
DK0393424T3 (da)	1996-02-05	Fremgangsmåde til fremstilling af 2,7-diazabicyclo(3.3.0)octaner
NO901171L (no)	1990-09-17	Fremgangsmaate til fremstilling av substituerte azetidinylpyridonkarboksylsyrederivater.
ATE554094T1 (de)	2012-05-15	Verfahren zur herstellung von 3-cephem- verbindungen
GR3002020T3 (en)	1992-12-30	Carboxylic acid synthesis process
DK0614908T3 (da)	1997-10-13	Fremgangsmåde til fremstilling af 3beta-aminocholansyrederivater.
DE60030118D1 (de)	2006-09-28	Zwischenprodukte zur synthese von benzimidazolverbindungen und ein verfahren zu ihrer herstellung
ATE179417T1 (de)	1999-05-15	Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung
DE69409776D1 (de)	1998-05-28	Verfahren zur Herstellung Pyridin-2,3-dicarboxylicsäure
PL310621A1 (en)	1995-12-27	Method of obtaining condensed carbapeneme derivatives
DE69706632D1 (de)	2001-10-18	Verfahren zur herstellung von 3-norcephem-verbindungen
MX9604347A (es)	1998-05-31	Derivados del acido 2-(4-pirazoliloxi-pirimidin-5-il) acetico.